The Rehab Gary Aston Jones: Treating Addiction With Dual Orexin Receptor Antagonists
Mar 24, 2023
52:01
Unlocking the Secrets of Sleep and Addiction: A Conversation with Dr. Gary Aston-Jones
In this episode, we are happy to welcome Dr. Gary Aston-Jones, Director of the Rutgers Brain Health Institute and head of the Aston-Jones Lab. Dr. Aston-Jones has dedicated his career to unraveling the mysteries of the brain and exploring how understanding the connection between sleep and addiction could lead to innovative treatments. Join us as we dive deep into the world of dual orexin receptor antagonists, a class of sleeping medications with promising potential for treating drug addiction.
Dr. Aston-Jones begins by shedding light on the crucial role of orexin, a neuropeptide that regulates arousal, wakefulness, and appetite, and how it is intricately linked to the complex process of addiction. He explains how the orexin system can be targeted using dual orexin receptor antagonists, which are designed to selectively block orexin receptors in the brain. By doing so, these medications not only promote sleep but also demonstrate intriguing possibilities for reducing cravings and drug-seeking behavior in individuals struggling with addiction.
As we delve deeper into the conversation, Dr. Aston-Jones shares fascinating insights from his research on the efficacy of dual orexin receptor antagonists in animal models. He discusses the implications of these findings for the development of new therapies and highlights the unique advantages of this class of medications in addressing both sleep disturbances and addiction.
We also explore the potential challenges and limitations of dual orexin receptor antagonists, including possible side effects, concerns about developing dependence on the medication, and the need for further clinical trials. Dr. Aston-Jones emphasizes the importance of a holistic approach to treating addiction, incorporating pharmacological interventions, behavioral therapies, and support systems to optimize outcomes.
Finally, Dr. Aston-Jones shares his vision for the future of addiction research and the role that the Rutgers Brain Health Institute will play in advancing our understanding of the brain, addiction, and mental health. Don't miss this compelling episode that offers hope and inspiration for those affected by addiction and showcases the groundbreaking work being done by Dr. Gary Aston-Jones and his team at the Aston-Jones Lab.
Please visit our websites at https://drleeds.com and https://therehab.com.
In this episode, we are happy to welcome Dr. Gary Aston-Jones, Director of the Rutgers Brain Health Institute and head of the Aston-Jones Lab. Dr. Aston-Jones has dedicated his career to unraveling the mysteries of the brain and exploring how understanding the connection between sleep and addiction could lead to innovative treatments. Join us as we dive deep into the world of dual orexin receptor antagonists, a class of sleeping medications with promising potential for treating drug addiction.
Dr. Aston-Jones begins by shedding light on the crucial role of orexin, a neuropeptide that regulates arousal, wakefulness, and appetite, and how it is intricately linked to the complex process of addiction. He explains how the orexin system can be targeted using dual orexin receptor antagonists, which are designed to selectively block orexin receptors in the brain. By doing so, these medications not only promote sleep but also demonstrate intriguing possibilities for reducing cravings and drug-seeking behavior in individuals struggling with addiction.
As we delve deeper into the conversation, Dr. Aston-Jones shares fascinating insights from his research on the efficacy of dual orexin receptor antagonists in animal models. He discusses the implications of these findings for the development of new therapies and highlights the unique advantages of this class of medications in addressing both sleep disturbances and addiction.
We also explore the potential challenges and limitations of dual orexin receptor antagonists, including possible side effects, concerns about developing dependence on the medication, and the need for further clinical trials. Dr. Aston-Jones emphasizes the importance of a holistic approach to treating addiction, incorporating pharmacological interventions, behavioral therapies, and support systems to optimize outcomes.
Finally, Dr. Aston-Jones shares his vision for the future of addiction research and the role that the Rutgers Brain Health Institute will play in advancing our understanding of the brain, addiction, and mental health. Don't miss this compelling episode that offers hope and inspiration for those affected by addiction and showcases the groundbreaking work being done by Dr. Gary Aston-Jones and his team at the Aston-Jones Lab.
Please visit our websites at https://drleeds.com and https://therehab.com.